Recent studies have identified defects in IL-2R signaling in T1D patients (72) and the diabetes susceptibility locus, Idd3, which contains IL-2 was recently shown to control Treg function through an effect on APC (73–75). The gene discussed is IL2; the disease is diabetes mellitus.